NKp46 modulators (Innate Pharma)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameNKp46 modulators (Innate Pharma)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNatural cytotoxicity triggering receptor 1 modulators
TargetsNatural cytotoxicity triggering receptor 1
Therapy Area/IndicationsInflammationNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesInnate Pharma SA
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesInnate Pharma SA
Active IndicationsN/A
Inactive IndicationsInflammationNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A